Empty Intravenous (IV) Bags Market Report 2026

Empty Intravenous (IV) Bags Market Overview

• Empty Intravenous (IV) Bags market size has reached to $7.15 billion in 2025 • Expected to grow to $12.51 billion in 2030 at a compound annual growth rate (CAGR) of 11.6% • Growth Driver: Driving Forces Surge In Surgical Procedures Fueling Growth Of Empty Intravenous (IV) Bag Market • Market Trend: Leading Companies In The Empty Intravenous (IV) Bags Market Pioneering Sustainable Recycling Initiatives • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Empty Intravenous (IV) Bags Market?

Empty intravenous (IV) bags are sterile, flexible containers designed for the administration of fluids, medications, or nutrients directly into a patient's bloodstream. These bags are used in medical settings to prepare and deliver IV solutions. The bags come in various sizes and materials, typically equipped with ports for easy connection to IV lines and infusion sets. The main types of empty intravenous (IV) bag are single chamber and dual chamber. A single-chamber empty intravenous (IV) bag is a sterile container used for preparing and administering fluids or medications intravenously, typically consisting of a single compartment. The products encompass polyvinyl chloride and non-polyvinyl chloride variants, constructed from materials such as polypropylene, polyester ether, ethylene vinyl acetate, and others, offering capacities ranging from 50 ml to 100 ml, 100 ml to 250 ml, 250 ml to 500 ml, and above 500 ml. These bags are used for applications mainly in hospitals, clinics, and others.

What Is The Empty Intravenous (IV) Bags Market Growth Forecast?

The empty intravenous (iv) bags market size is expected to see rapid growth in the next few years. It will grow to $12.51 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing demand for infusion-based treatments, growing aging population, rising surgical and critical care procedures, expansion of outpatient and clinic-based care, increasing preference for safer iv packaging materials. Major trends in the forecast period include growing shift toward non-pvc intravenous bags, rising demand for multi-chamber iv bag configurations, increasing use of iv bags in critical and acute care settings, expansion of ready-to-mix and customized iv solutions, rising focus on sterility and contamination prevention.

Global Empty Intravenous (IV) Bags Market Segmentation

1) By Product: Polyvinyl Chloride, Non-Polyvinyl Chloride 2) By Chamber Configuration: Single Chamber, Multi-Chamber 3) By Material: Polypropylene, Polyester Ether, Ethylene Vinyl Acetate (EVA), Other Materials 4) By Capacity: 50 ML - 100 ML, 100 ML - 250 ML, 250 ML - 500 ML, Above 500 ML 5) By Application: Hospital, Clinic, Other Applications Subsegments: 1) By Polyvinyl Chloride (PVC): Flexible PVC IV Bags, Rigid PVC IV Bags 2) By Non-Polyvinyl Chloride (Non-PVC): Ethylene Vinyl Acetate (EVA) IV Bags, Other Non-PVC Materials

What Are The Drivers Of The Empty Intravenous (IV) Bags Market?

The rising number of surgical procedures is expected to propel the growth of the empty intravenous (IV) bag market going forward. Surgical procedures are medical interventions or treatments that involve invasive techniques to address or correct health conditions, injuries, or abnormalities within the body. Surgical procedures are increasing due to advancements in medical technology, an aging population, the prevalence of chronic diseases, improved access to healthcare, and patient demand and expectations. Empty intravenous (IV) bags play a critical role in providing essential fluids, medications, blood products, and anesthesia support during surgical procedures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, in 2023, plastic surgeries increased by 5%, while minimally invasive procedures rose by 7% compared to the previous year. Therefore, the rising number of surgical procedures is driving the growth of the empty intravenous (IV) bag industry. The high prevalence of chronic diseases is expected to propel the growth of the empty intravenous (IV) bags market going forward. Chronic diseases are long-lasting conditions that usually develop slowly and persist over an extended period, often for the rest of a person's life. Chronic diseases are increasing due to aging populations, lifestyle factors, urbanization, obesity epidemics, healthcare access and quality, increased stress, and mental health issues. Empty IV bags are crucial for preparing and administering personalized medication solutions, facilitating home infusion therapy, nutrition support, hydration, and palliative care, while also serving as a platform for research and development in chronic disease treatment. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency. in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the high prevalence of chronic diseases is driving the growth of the empty intravenous (IV) bag industry.

Key Players In The Global Empty Intravenous (IV) Bags Market

Major companies operating in the empty intravenous (iv) bags market are Fresenius Medical Care AG KGaA, Becton Dickinson and Company, Amcor LLC, Baxter International Inc., Grifols S.A., Hospira Inc., Nipro Corporation, B. Braun Medical Inc., ICU Medical Inc., RENOLIT Healthcare, Kiefel GmbH, BAUSCH Advanced Technology Group, Technoflex, Sippex IV bags, AdvaCare Pharma Limited, Tacy Medical Inc., Polycine GmbH, JW Life Science Corp, Mitra Industries Private Limited, Terumo Corporation

Global Empty Intravenous (IV) Bags Market Trends and Insights

Major companies operating in the Empty intravenous (IV) bags market are focused on advancing intravenous (IV) bags recycling by developing sustainable collection, processing, and repurposing methods to reduce environmental impact and promote circular economy practices within the healthcare sector. Advancing intravenous (IV) bags recycling refers to the development and enhancement of processes and systems for recycling used IV bags, which are commonly made from plastic materials like polyvinyl chloride (PVC) or other recyclable polymers. For instance, in December 2023, Baxter International Inc., a US-based company that offers healthcare services launch of the first intravenous (IV) bag recycling pilot program in the United States, in collaboration with Northwestern Medicine. This initiative aims to address the environmental impact of single-use plastic IV bags, which are commonly disposed of in landfills after use.

Regional Outlook

North America was the largest region in the empty intravenous (IV) bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Empty Intravenous (IV) Bags Market?

The empty intravenous (IV) bags market consists of sales of sterile IV bags, pressure-resistant bags, and light-protective bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.